16
Jun
2026
Kinhoo Pharmaceutical Co., Ltd.
Exhibitor at CPHI & PMEC China 2026 stand E10B25, Pharma Ingredients
About Us
Categories
-
Country/Region:China
-
On CPHI since:2017
-
Employees:500 - 999
Company types
Event information
CPHI & PMEC China 2026
-
16 Jun 2026 - 18 Jun 2026
-
Shanghai New International Expo Center
-
Visit us at stand E10B25, Pharma Ingredients
Products Featured at CPHI & PMEC China 2026
-
Product Sorafenib tosylate
Sorafenib tosylate (CAS No.: 475207-59-1) Indications: For the treatment of patients with advanced renal cell carcinoma (RCC). For the treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of patients with locally recurrent or metastatic, progressive, differentia... -
Product Vardenafil hydrochloride
Vardenafil hydrochloride (CAS No.: 330808-88-3)Indications: For the treatment of erectile dysfunction.
-
Product Lenvatinib mesylate
Lenvatinib mesylate (CAS No.: 857890-39-2)Indications: For the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid carcinoma (D... -
Product Ibuprofen arginine
Ibuprofen arginine (CAS No.: 57469-82-6)Indications: For relief of toothache, dysmenorrhea, pain caused by injury (e.g., athletic injuries), joint and ligament pain, back pain, headache, and fever caused by influenza.
-
Product Ferrous succinate
Indications: For the prevention and treatment of Iron Deficiency Anemia (IDA).




